Average weight loss associated with metformin
Pro Research Analysisby 
Searched over 200M research papers
Average Weight Loss with Metformin: Key Findings
Short-Term Weight Loss with Metformin in Diabetes and Obesity
Studies consistently show that metformin leads to modest but significant weight loss in people with type 2 diabetes and those with obesity. In newly diagnosed type 2 diabetes patients, an average weight loss of about 2 kg was observed after 16 weeks of metformin treatment, with greater weight loss seen in those with higher baseline BMI . In elderly patients (over 60 years), a meta-analysis found an average weight loss of about 2.2 kg compared to placebo over at least 12 weeks .
Long-Term Weight Loss: Diabetes Prevention Program (DPP) Insights
The Diabetes Prevention Program (DPP) and its long-term follow-up (DPPOS) provide some of the most robust data. Over an average of 2.8 years, participants taking metformin lost about 2.1 kg, and this weight loss was largely maintained over 10 to 15 years, with an average sustained loss of about 2–2.5 kg 25. This long-term effect was directly related to how consistently participants took metformin .
Weight Loss in Non-Diabetic and Obese Individuals
In non-diabetic individuals with obesity, metformin also results in weight loss. One real-world study found an average weight loss of 5.8 kg (about 5.6% of body weight) over 6 months, with greater effects in those with higher insulin resistance . Another study showed similar weight loss (about 6% of baseline weight) in both people with and without diabetes or prediabetes after 6–12 months of metformin monotherapy .
Meta-Analyses and Systematic Reviews: Quantifying the Effect
Meta-analyses confirm that metformin leads to a modest reduction in BMI, typically around 1 unit (kg/m²), which translates to a weight loss of about 2–3 kg for most adults 67. The effect is more pronounced in people with higher baseline BMI and in those with simple obesity . The weight loss effect does not appear to increase significantly after 6 months of treatment .
Mechanism: Appetite Suppression and Calorie Intake
Metformin’s weight loss effect is partly due to reduced calorie intake and appetite suppression. Studies show that metformin decreases hunger and leads to lower food consumption, with higher doses having a stronger effect .
Special Populations: Elderly and Cancer Survivors
In elderly patients, metformin is associated with small but significant weight loss and improvements in cholesterol levels, without increasing the risk of unintentional weight loss . In overweight or obese breast cancer survivors, metformin combined with lifestyle intervention led to a mean weight loss of about 5.5% over six months .
Conclusion
Metformin is associated with modest average weight loss, typically ranging from 2 to 6 kg (about 2–6% of baseline body weight), depending on the population and duration of treatment. The effect is generally greater in those with higher baseline BMI or insulin resistance and is sustained with continued use. While not as potent as some dedicated weight loss medications, metformin’s weight loss is clinically meaningful, especially for people with type 2 diabetes or obesity 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic